Prostaglandin E2 Cooperates with TRANCE in Osteoclast Induction from Hemopoietic Precursors: Synergistic Activation of Differentiation, Cell Spreading, and Fusion
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
It was recently found that osteoblastic cells express TRANCE (tumor necrosis factor-related activation-induced cytokine), a newly identified member of the tumor necrosis factor superfamily, and that expression was increased by calciotropic hormones. Furthermore, soluble recombinant TRANCE induces osteoclast formation and resorption in stroma-free populations of hemopoietic precursor cells. However, overexpression of the decoy receptor osteoprotegerin in vivo shows that there are substantial differences in the sensitivity of different sites to resorption-inhibition, suggesting that either alternative ligands exist or the sensitivity of osteoclasts to TRANCE can be modified by cofactors. We therefore tested the possibility that cofactors might enhance osteoclast formation by TRANCE. We found that the number of tartrate-resistant acid phosphatase-positive and calcitonin receptor-positive cells was increased by a factor of 10 by the presence of PGE2 in the absence of stromal cells. Moreover, although the tartrate-resistant acid phosphatase-positive cells that formed in TRANCE alone were typically mononuclear and poorly spread, the addition of PGE2 induced the formation of large, well spread multinuclear cells. There was an increase in bone resorption that corresponded with the increase in osteoclast number. PGE2 did not synergize with TRANCE for resorption-stimulation in mature cells. 8-Bromo-cAMP showed a similar syngergistic effect on osteoclastic differentiation. Thus, PGE2 appears to stimulate bone resorption through a direct effect on hemopoietic precursors, primarily through a synergistic effect on the ability of TRANCE to induce osteoclastic differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
GREENWOOD, F., HUNTER, W., & GLOVER, J. (1963) · Biochemical Journal · doi:10.1042/bj0890114 · Cited by 10,152
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
HUNTER, W. M., & GREENWOOD, F. C. (1962) · Nature · doi:10.1038/194495a0 · Cited by 6,919
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Prostaglandins: Stimulation of Bone Resorption in Tissue Culture
KLEIN, D. C., & RAISZ, L. G. (1970) · Endocrinology · doi:10.1210/endo-86-6-1436 · Cited by 969
Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H.-L., Steinman, R. M., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2075 · Cited by 853
Self-citationFuller, K., Wong, B., Fox, S., Choi, Y., & Chambers, T. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.997 · Cited by 561
Histochemical Demonstration of Acid Phosphatases With Naphthol AS-Phosphates
(1958) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/21.3.523 · Cited by 498
Prostaglandins as Potentiators of Increased Vascular Permeability in Inflammation
WILLIAMS, T. J., & MORLEY, J. (1973) · Nature · doi:10.1038/246215a0 · Cited by 477
Nicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454
CHAMBERS, T. J., McSHEEHY, P. M. J., THOMSON, B. M., & FULLER, K. (1985) · Endocrinology · doi:10.1210/endo-116-1-234 · Cited by 422
Tashjian, A. H., Voelkel, E. F., Lazzaro, M., Singer, F. R., Roberts, A. B., Derynck, R., Winkler, M. E., & Levine, L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4535 · Cited by 380
Fuller, K., Owens, J. M., Jagger, C. J., Wilson, A., Moss, R., & Chambers, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1733 · Cited by 362
Biochemistry of Lipids and Membranes
Vella, F. (1986) · Biochemical Education · doi:10.1016/0307-4412(86)90033-6 · Cited by 326
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312
Biology and Physiology of the Osteoclast
Rifkin, B. R. (1992) · Cited by 289
Tashjian, A. H., & Levine, L. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)90638-1 · Cited by 277
Rieser, C., Böck, G., Klocker, H., Bartsch, G., & Thurnher, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1603 · Cited by 274
TASHJIAN, A. H., VOELKEL, E. F., LAZZARO, M., GOAD, D., BOSMA, T., & LEVINE, L. (1987) · Endocrinology · doi:10.1210/endo-120-5-2029 · Cited by 228
Warshawsky, H., Goltzman, D., Rouleau, M. F., & Bergeron, J. J. (1980) · The Journal of cell biology · doi:10.1083/jcb.85.3.682 · Cited by 210
Akatsu, T., Takahashi, N., Debari, K., Morita, I., Murota, S., Nagata, N., Takatani, O., & Suda, T. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040106 · Cited by 187
Platelet-Derived Growth Factor Stimulates Bone Resorption via a Prostaglandin-Mediated Mechanism*
Tashjian, A. H., Hohmann, E. L., Antoniades, H. N., & Levine, L. (1982) · Endocrinology · doi:10.1210/endo-111-1-118 · Cited by 183
Jimi, E. (1995) · Endocrinology · doi:10.1210/en.136.2.808 · Cited by 169
HATTERSLEY, G., & CHAMBERS, T. J. (1989) · Endocrinology · doi:10.1210/endo-125-3-1606 · Cited by 152
Chambers, T. J., Owens, J. M., Hattersley, G., Jat, P. S., & Noble, M. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5578 · Cited by 145
SHINAR, D. M., & RODAN, G. A. (1990) · Endocrinology · doi:10.1210/endo-126-6-3153 · Cited by 127
HATTERSLEY, G., & CHAMBERS, T. J. (1989) · Endocrinology · doi:10.1210/endo-124-4-1689 · Cited by 121
Suzuki, H. (1996) · Endocrinology · doi:10.1210/en.137.11.4685 · Cited by 114
A community effect in muscle development
Gurdon, J. B., Tiller, E., Roberts, J., & Kato, Y. (1993) · Current Biology · doi:10.1016/0960-9822(93)90139-f · Cited by 112
Effect of prostaglandins E1, E2, and F2α on osteoclast formation in mouse bone marrow cultures
Collins, D., & Chambers, T. J. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060209 · Cited by 109
IL-10 modulates formation of osteoclasts in murine hemopoietic cultures
Owens, J., Gallagher, A. C., & Chambers, T. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.936 · Cited by 108
Pharmacological control of osteoclastic motility
Chambers, T. J., & Dunn, C. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405095 · Cited by 102
Hattersley, G., & Chambers, T. J. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041420125 · Cited by 82
Lorenz, J. J., Furdon, P. J., Taylor, J. D., Verghese, M. W., Chandra, G., Kost, T. A., Haneline, S. A., Roner, L. A., & Gray, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.836 · Cited by 48
Akatsu, T., Takahashi, N., Udagawa, N., & Suda, T. (1989) · Ensho · doi:10.2492/jsir1981.9.295 · Cited by 34
Cited by
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
BIOMECHANICAL AND MOLECULAR REGULATION OF BONE REMODELING
Robling, A. G., Castillo, A. B., & Turner, C. H. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095721 · Cited by 1,343
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
TRANCE, a TNF Family Member, Activates Akt/PKB through a Signaling Complex Involving TRAF6 and c-Src
Wong, B. R., Besser, D., Kim, N., Arron, J. R., Vologodskaia, M., Hanafusa, H., & Choi, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80232-4 · Cited by 592
Metadata
- Authors
- Wani, M. R.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1999-04-01
- Volume
- 140
- Issue
- 4
- Pages
- 1927-1935
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2105332564
- Cited by
- 172
- References
- 39
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.